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Abstract
Polyoma virus middle T antigen (ml) transforms the
T51 B cell line and induces the loss of the cytokeratin 8
and 14 pair (CK8/CK14) present in these rat
nonparenchymal liver epithelial cells (LECs), because
of the selective down-regulation of CKI4 gene
expression. To identify the initial steps of the mT-
induced signaling pathway(s) leading to this inhibition,
T51 B cells were transfected with vectors encoding the
NG59, d123, and 248M mT mutants, which are known to
interact in a differential manner with c-Src, Pl3-kinase,
and Shc. Immunofluorescence microscopy and
Northern blot analysis showed a loss of cytokeratins in
dl23 or 248M but not in NG59 mT mutant-containing
cells. An in vitro kinase assay demonstrated that only
the d123 and 248M mT mutants could associate with
c-Src. This c-Src-mediated action of mT on CKI4 gene
expression was further confirmed by adding the v-sm
gene product in T51 B cells. The assessment of the
transforming capacity of the mT mutants demonstrated
that the NG59 and dl23 mT mutants were
nontransformant, whereas the 248M mT mutant
expressed an appreciable transforming activity. These
results show that the down-regulation of CKI4 gene
expression by mT in the LEC line T51 B is dependent on
the association with the c-Src tyrosine kinase, but
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interestingly, this c-Src-mediated action of mT can
occur in the absence of transformation. Furthermore,
when coupled with recent data on the plasticity of
LECs, the present findings provide the first essential
element in our definition of the signaling pathway(s)
that link growth/differentiation events with CK gene
regulation in typical simple ep’,thelial cells.
Introduction
CKs4 are the IF proteins of epithelial cells and consist of a large
family of at least 20 acidic (type I IF) or neutral-basic (type II IF)
peptides (1-3). CK IFs are heteropolymers assembled from
dimers containing one polypeptide of each type (3, 4). More-
over, various CK subsets are expressed differentially, depend-
ing on the type of epithelium and its state of differentiation; for
example, the CK8/CK18 pair is found in cells of simple epithelia
(e.g., liver), whereas the CK5/CK14 pair is present in keratino-
cytes of the basal layer of stratified epithelia (1 , 2). Vimentin, a
type Ill IF protein, is present in cells of mesenchymal origin, but
is also found in some epithelial cells of highly specialized tissues
and in culture (1). Although the biological function of CKs in
nonkeratinized epithelial cells has yet to be elucidated, point
mutations in epidermal CK genes dramatically perturb the in-
tegrity of keratinocytes (5-7), thus establishing a direct func-
tional link between CK gene expression and the cellular differ-
entiation pattern in epidermis (8).
The polyoma virus mT, a membrane-bound oncogene (9,
10), associates with c-Src (1 1, 12), as well as with other
members of the c-Src family, such as c-Fyn and c-Yes
(13-1 5). This association activates the tyrosine-kinase activ-
ity of c-Src (16, 17) toward a number of substrates, including
mT itself, primarily on Tyr3l 5 and to a lesser extent on
Tyr250 (18). This results in the association of mT with the
85-kDa subunit of P13-kinase (19-24) and of the Shc adaptor
protein (25, 26), respectively. Extensive genetic and bio-
chemical evidence from studies performed in fibroblasts has
indicated that mT association and/or activation of c-Src,
Pl3-kinase, and Shc are required for their transformation.
Mutant forms of mT that do not associate with c-Src are
totally devoid of transforming ability in fibroblastic cells (e.g.,
NG59; Ref. 27). Mutants that do associate with c-Src but do
not become phosphorylated at Tyr3l 5 are unable to asso-
ciate with and activate P13-kinase and are transformation
deficient (e.g. , 1178T, dI23; Ref. 27). Other mutants (e.g.,
248M, 250F; Refs. 26, 28, 29) that activate the Src-tyrosine
4 The abbreviations used are: CK, cytokeratin; IF, intermediate filament;
LEC, liver nonparenchymal epithelial cell; mT, middle tumor antigen; P13-
kinase, phosphatidylmnositol 3-kinase.￿7￿- ;￿ #{149}1
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Fig. 1 . Mutant rnT expression in
T51B cells. Irnrnunofluorescence
staining of mT in control Tneo (a),
TrnT(b), TNG59 (c), Tdl23 (d), and
T248M (e) cells. Fixed cells were
first incubated with the C4 super-
natant and then with a biotin-con-
jugated antirat antibody followed
by the FITC-Iabeled streptavidin.
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kinase as well as the Pl3-kinase but do not interact with Shc
are also transformation deficient. Thus, mT and its various
mutant forms offer ideal tools for examining the role of down-
stream signaling elements in the regulation of cell growth-
and/or differentiation-related events, particularly within the
context of neoplastic transformation.
We have recently observed that wild-type mT transforms the
rat LEC line 151 B and induces the loss of the differentiation-
related CK8/CK14 pair normally present in these cells, because
of a down-regulation of CK14 gene expression (30). Further
analyses involving polyoma virus small T or large T transfection
of T51 B cells, mT transfection of rat hepatic cell lines express-
ing different CK pairs, and mT transfection of rat keratinocytes
have led to the conclusion that the polyoma virus oncogene
action on CK gene expression is restricted to the action of mT
on CK14 in rat LECs (58). In the present study, T51 B cells were
transfected with vectors encoding NG59, d123, or 248M mT
mutants, or v-Src, and the CK gene expression was assessed
at the mRNA and protein levels. The capacity ofthe mT mutants
to transform these LECs was also assessed. The results show
that the selective inhibition of CK14 gene expression by mT in
the LEC line T51B is dependent on the association of c-Src but
independent of transformation.
Results
Expression of mT Mutant Constructs in T51 B Cells. Our
recent data have shown that mT antigen inhibits CK14 gene
expression in T51 B cells (30). Because CK8 cannot form CK
IFs in the absence of its partner and is rapidly degraded (31,
32), CK8 was also lost after mT expression (30). To define the
immediate mT-triggered events leading to the transmission
of the CKl 4 inhibition signal, mT-mutant molecules defective
in distinct elements of the mT-mediated signaling pathway
were stably expressed in T51 B cells. Vectors encoding the
NG59, d123, and 248M mT mutants (PZIP-NG59, PZIP-dl23,
pZIP-248M, respectively) under the control of the Moloney
murine leukemia virus promoter were introduced through
transfection in T51 B cells with G41 8 resistance selection (see
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Fig 2. Analysis of tyrosine kinase activity associated with mutant rnT
antigens in T51 B cells. Washed rnT immunoprecipitates prepared from
extracts of control Tneo (Lane 1), TrnT (Lane 2), TNG59 (Lane 3), Td123
(Lane 4), and T248M (Lane 5) cells were incubated with [￿y-32PJATP and
electrophoresed on a 10% acrylarnide-SDS gel. The gel was treated with
NaOH, dried, and exposed to Kodak XAR-5 film. The band of M￿ 85,000
corresponds to the p85 subunit of P13-kinase, which has coprecipitated
with rnT and c-Src.
“Materials and Methods”). Resistant clones (4-7 per trans-
fection), designated TNG59, Td123, and T248M, respectively,
were allowed to grow and were tested for mT expression.
Northern analysis with a mT-specific probe (data not shown)
and immunofluorescence staining, using the C4 antibody,
revealed the expression of the NG59 (Fig. 1c), dl23 (Fig. 1d),
and 248M (Fig. 1e) mT mutant antigens in representative
clones, as in the TmT clones (Fig. lb).
To examine the capacity of the various mT mutants to
associate with and to activate c-Src, an in vitro kinase assay
was performed on immunoprecipitated mT from transfected
T51 B cell lysates (Fig. 2). As observed before in fibroblasts,
no phosphorylation was detected using lysates from NG59-
expressing cells, because this mutant does not interact with
the c-Src tyrosine kinase (Fig. 2, Lane 3; Ref. 27). The phos-
phorylation of dI23 mT was low, as expected from the factI 2 3 4 5
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Fig. 3. Immunofluorescence staining of CK8 in mutant mT-containing
T51 B cells. The Tneo (A), TNG59 (B), Td123 (C), and T248M (D) cells were
reacted first with the mouse monoclonal antibody against CK8 and then
with a FITC-labeled goat antimouse immunoglobulin.
that the major phosphorylation site, Tyr3l 5, is absent in this
mutant (Lane 4; Ref. 27). On the other hand, the phospho-
rylation of 248M mT was comparable to that of wild-type mT
(Lanes 5 and 2; Ref. 26).
CK Gene Expression in T51 B Cells Containing mT
Mutants. CK gene expression was first assessed at the pro-
tein level in the mT mutant-containing clones by indirect immu-
nofluorescence microscopy of CK14 IFs, using a specific anti-
body (Fig. 3). As stated above, CKs are always expressed as
pairs, and the absence of one CK leads to the degradation of its
partner (31 , 32). Control Tneo cells contained CK IFs (Fig. 3A)
that exhibited the typical pattern observed in nontransfected
T51 B cells (33). The expression of the NG59 mT mutant, which
is devoid of associated tyrosine kinase activity, had no effect
(Fig. 3B). Interestingly, the CK IFs were lost in Td123 and T248M
cells (Fig. 3, C and D), in which the mT mutants still stimulated
c-Src tyrosine kinase activity.
We also determined whether mT mutants dl23 and 248M
exerted the same effect on CK gene expression at the mRNA
level (Fig. 4). Northern analysis showed that CK14 mRNAs were
absent in TmT cells (Fig. 4, Lane 2) as well as in Tdl23 (Fig. 4,
Lane 4) and T248M cells (Fig. 4, Lane 5), whereas the CK8
mRNAs as well as actin and vimentin mRNAs remained present
in TmT cells (Fig. 4, Lane 2), TNGS9 cells (Fig. 4, Lane 3), Td123
cells (Fig. 4, Lane 4), and T248M cells (Fig. 4, Lane 5). The
changes observed in CK8, vimentin, and actin mRNA levels
were due to fluctuations in RNA loads, as revealed by ethidium
bromide staining (data not shown). Nevertheless, the important
observation here is that d123 and 248M mutants inhibited the
expression of the CK14 gene, just as wild-type mT did, but not
that of the CK8, vimentin, or actin genes. Together, these re-
suIts indicate that c-Src is essential for the transmission of the
CK14 gene-inhibitory signal by mT, whereas P1-3 kinase and
Shc are not, because dl23 and 248M mutants do not interact
with P13 kinase and Shc, respectively.
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Fig. 4. Northern analysis of CK, vimentin, and actin mRNA expression in
mutant mT-containing T51B cells. Samples of 20 j.￿g RNA of Tneo (Lane
1), TmT(Lane 2), TNG59 (Lane 3), Tdl23 (Lane 4), and T248M (Lane 5) cells
were resolved by 1.5% formaldehyde-agarose gel electrophoresis, trans-
ferred to a nylon membrane by blotting, and hybridized with 32P-labeled
probes corresponding to CK14, CK8, vimentin, and actin cDNAs.
To confirm the requirement for c-Src activation, CK gene
expression was evaluated in T51 B cells stably transfected
with a construct encoding the v-src gene product and sub-
mitted to G41 8-resistance selection. Resistant clones were
then examined by indirect immunofluorescence microscopy,
using a Src-specific antibody (Fig. 5); a positive staining was
observed in all of the TSrc cells (Fig. 5A, c). With regard to the
effect of v-Src on CK gene expression, the typical CK IFs
seen in the perinuclear region of Tneo cells (Fig. 5A, b) were
lost in all of the TSrc cells (Fig. 5A, d), as in the case of TmT
cells (30, 58). The same results were obtained when we used
the anti-CK8 antibody (data not shown).
The data from the Northern blot analysis of the CK mRNAs
in TSrc cells (Fig. SB, Lane 3) demonstrated that the loss of
CK14 and CK8 was due to the absence of CK14 mRNAs
only, as was the case for TmT (Fig. SB, Lane 2, and Fig. 4,
Lane 2; Ref. 30), Tdl23, and T248M cells (Fig. 4, Lanes 4 and
5). Under these conditions, the expression of CK8, vimentin,
and actin mRNAs was maintained in the TSrc cells (Fig. SB,
Lane 3).
Transforming Activity of MT Mutants in T51 B Cells. As
stated in the “Introduction,” the mT mutants used here are
nontransforming in fibroblastic cells (27-29). In the present
study, the capacity of Tneo, TmT, TNG59, Td123, and T248M740 CK14 Inhibition via c-Src Association to mT
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Fig. 5. A, immunofluorescence staining of v-Src and CK1 4 in T51 B cells transfected with v-src. Control Tneo (a and b) and TSrc (c and a) cells were reacted
with mouse monoclonal antibodies against Src (a and c) and CK14 (b and a). The second reactions were made using biotin-conjugated antimouse or
antirabbit immunoglobulin followed by incubation with FITC-labeled streptavidin. Src antibodies recognize the viral and the corresponding cellular
oncoprotein. B, Northern analysis of CK, vimentin, and actin mRNA expression in T51 B cells transfected with v-src. Total RNA (20 ￿g) isolated from Tneo
(Lane 1), TrnT (Lane 2), and TSrc (Lane 3) cells was electrophoresed in a 1.5% agarose-formaldehyde gel, transferred to a nylon membrane by blotting, and
hybridized to 32P-labeled probes corresponding to CK14, CK8, vimentin, and actin cDNAs.
Table 1
cells
Transforming capacity of mT, m T mutants, and v-Src in T51 B
Clone Oncogene
Src
activationa
Agar
Tumorigenicity
Animals with tumors/
animals injectedb
Time’￿
Tneo Control - - 0/9
TmT Wild-type + + 6/6 5
TNG59 NG59 mutant - - 0/6
Td123 dl23 mutant + - 0/13
T248M 248M mutant + + 7/7 8
TSrc v-Src + + 6/6 6
a Based on an in vitro phosphorylation assay (data from Fig. 2).
b Injected animals were examined for tumor formation over a 26-week
period.
C Number of weeks for the tumors to reach a size of 1 cm.
cells to produce foci in soft agar and to form tumors in
syngeneic animals was assessed (Table 1). Although a very
good correlation was obtained between the two cell param-
eters, the tumor formation provided a clear-cut answer.
Tneo, TNG59, and Tdl23 cells yielded no tumors, even after
26 weeks after transplantation, whereas TmT and T248M
cells formed important tumors within less than 5 and 8
weeks, respectively. As expected, the capacity of TSrc cells
to form tumors was comparable to that of TmT cells (Table 1).
Upon gross examination, the tumors formed by TmT cells
were characterized by a compact fibrous texture, whereas
those from T248M cells had a soft texture. These distinctive
tumor features reflected pronounced differences in tissue
architecture, as demonstrated in H&E-stained histological
sections (Fig. 6). Indeed, TmT cells were organized as com-
pact units, whereas T248M cells had a larger diameter and
were much more basophilic.
Discussion
We recently reported that the introduction of wild-type mT
induces a down-regulation of CK14 gene expression in T51 B
cells (30) and that this mT action on a LEC CK gene is highly
selective (58). The present findings obtained from NG59,
d123, and 248M mT mutants and v-Src demonstrate that
association of the c-Src tyrosine kinase activity with mT is
required for the inhibition of CK14 gene expression.
Moreover, this Src-mediated action of mT on CK14 gene
expression in LECs takes place in the absence of neoplastic
transformation.
In all of the cell types examined thus far, mT is largely
targeted to the cell membranes (9, 10), where it associates
with the c-Src tyrosine kinase and other related enzymes
(11-15). This leads to c-Src activation (16, 17) and to the
autophosphorylation of mT on Tyr 31 5 and Tyr 250 (18),
which in turn interact with the p85 subunit of P13-kinase
(19-24) and Shc (25, 26). These observations provided the
rationale for using mT mutants that interact in a differential
manner with these components to identify the immediate
downstream transducing events involved in the inhibition of
CK14 gene expression. The present results show that the
NG59 mT mutant, which does not interact with c-Src, does
not trigger the inhibitory effect, whereas dl23 and 248M mT
mutants, which bind to and activate c-Src, both transmit this
signal. In addition, the d123 and 248M mT mutants cannot
interact with P13-kinase and Shc, respectively, suggesting
that P13-kinase and Shc are not required. In agreement with
this, treatment of wild-type mT-containing TS1 B cells for 6 h
with the potent P13-kinase inhibitor Wortmannin (Refs. 34
and 35; 0.5-1 ￿LM) reduced the P13-kinase activity by up to
80% but did not restore CK14 gene expression, further sup-￿‘ . t .￿. ￿ ￿
￿ .￿ ￿
￿ : ￿ ￿
￿#{176} ?j ￿
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Fig. 6. Tissue sections from TrnT and T248M cell-derived tumors. As
reported in Table 1, TmT and T248M cells injected subcutaneouly into
newborn Fischer rats formed tumors at 5 and 8 weeks, respectively. H&E
staining; x400.
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5 I. Royal and N. Marceau, unpublished results. 6 I. Royal and N. Marceau, unpublished data.
porting the conclusion that P13-kinase is not essential.5 Thus,
these observations strongly suggest that the association
with and activation of the c-Src tyrosine kinase by mT is the
primary event in the transmission of the signal to TS1 B cell
nuclei. Moreover, wild-type mT and several mT mutants,
including d123 and 248M but not NG59, interact with the
protein phosphatase 2A (36-38), which may regulate the
formation and/or stability of mT:c-Src complexes (39). If this
is the case, one could also argue that protein phosphatase
2A is somehow participating with c-Src in the down-regula-
tion of CK14 gene expression.
Although mT also binds to c-Yes and c-Fyn, two other mem-
bers of the c-Src family of tyrosine kinases (13-15), c-Src nor-
mally contributes much more to the total level of mT-associated
tyrosine kinase activity than does either c-Yes or c-Fyn (40). The
same overall conclusion can be reached with regard to mT
transforming activity, on the basis of observations made on
cultured fibroblasts expressing antisense c-src RNA (41) and
also on transgenic mice carrying a MM7V/mT fusion gene
(mouse mammaiy tumor virus/mT gene; for mammary gland
targeting) crossed with mice beating a disrupted c-sm or c-yes
gene (42). In any event, considering the large degree of redun-
dancy for c-Src, c-Yes, and Fyn throughout development (43),
ft is likely that they may activate the same downstream signaling
pathway(s) in various cell types. This important mT-related sig-
naling issue will be addressed as part of our future studies on
the actual interplay between cytoplasmic events that regulate
CK14 gene expression and those that result in TS1 B cell trans-
formation.
Earlier data have shown that spontaneously transformed
TmT and aflatoxin B1-transformed T51 B cells maintain their CKs
(30), thus providing the first piece of evidence suggesting
that the inhibition of CK14 gene expression in mT-containing
TS1 B cells is linked to specific mT-triggered signaling events,
rather than to transformation per se. The present results
provide the converse evidence, in the sense that the pres-
ence of a transformation-defective mT mutant, such as d123,
still leads to inhibition. Interestingly, the fact that the 248M
mT mutant can transform T51 B cells but is defective in
fibroblastic cells (25, 26, 28, 29) suggests either that the
crucial events required for full transformation are depend-
ent on cell lineage, or that the level of 248M mT mutant
expression is high enough to reach a threshold level of
activation of the inhibitory pathway. Nevertheless, the data
from the tumor typing analyses clearly demonstrate major
phenotypic differences in the tumors obtained with wild-
type mT versus 248M mT mutant-containing T51 B cells
(Fig. 6), and in turn, they differ from those obtained with
spontaneously transformed and aflatoxin B1-transformed
TSl B cells (data not shown). On the basis of all of these
findings, we can hypothesize that transformation-related
signals most likely generated at the surface membrane can
be transmitted to the nucleus along various differentiation-
related pathways.
The fact that mT shares many common features with acti-
vated receptortyrosine kinases suggests that the modulation of
receptor tyrosine kinase activity could modulate CK14 gene
expression in T51 B cells and other LECs. This seems to be the
case, because we obtained data showing that triggering the
epidermal growth factor receptor in TS1 B cells and in primary
cultures of LECs resulted in the down-regulation of CK14 gene
expression.6 Moreover, considering that epidermal growth fac-
tor is a very potent factorfor liver cell growth, the present results
establish a link between basic mT-mediated growth events and
CK14 gene expression in LECs.
The data accumulated thus far on the specific expression
of CK14 and the selective inhibitory action of mT on the
expression of this CK gene in LECS (30, 44 and present data)
can be put into a new perspective that takes into account the
importance of LECs in liver biology. Although the role of
LECs is unclear, their high level of plasticity has led to the
suggestion that they may constitute “facultative liver stem
cells” (45). However, on the basis of data showing that CK14-
expressing LECs are localized in both bile ductal structures
and the Glisson capsule, we have proposed that LECs con-
stitute a population of specialized epithelial cells that may be
blocked at a “differentiation window,” a stage at which liver
cells are most sensitive to transformation (46). In this context,
the present data provide the first essential element in our
definition of the signaling pathway(s) that link growth/differ-
entiation-mediated events and CK gene regulation in typical742 CK14 Inhibition via c-Src Association to mT
simple epithelial cells exhibiting a high transformation
susceptibility.
Materials and Methods
Cell LInes. The T51 B cell line was derived from a primary adult Fisher rat
liver cell culture (47, 48). The cells were grown in MEM-a medium (Life
Technologies, Inc.) containing 10% inactivated fetal bovine serum (30 mm
at 56#{176}C; Life Technologies, Inc.), 100 units/mI penicillin, and 100 pg/mI
streptomycin.
Expression of Wild-Type or Mutant ml Antigens. Cells were plated
at a density of 1o￿ cells/cm2 and transfected the next day by the calcium
phosphate technique of Okayama and Chen (49). After 2 weeks of selec-
tion with G418 (400 pg/mI; Life Technologies, Inc.), between 5 and 15
colonies were picked and screened for the highest level of oncogene
expression. Four to seven colonies were further examined for CK gene
expression. Retroviral vector constructs of pZIPNe0SV(X)l (50)-bearing
mutant mT coding DNA fragments were transfected (3-4 mg/35-mm
dish): pZIP-NGS9; pZIP-d123(27); and pZIP-248M, which was constructed
by ligation of the BamHI backbone fragment of pZlP-NG59 with the
BamHI/BgllI insert of pBD15-248M (51), corresponding to the 248M mT
mutant coding sequence. As a control, we used the Tneo established cell
line, which corresponds to T51B cells transfected with the pRSVNe0
plasmid encoding the aminoglycosyl phosphotransferase gene, confer-
ring resistance to the neomycin analogue G418 (30). The TmT established
cell line corresponds to pMT3-transfected T51B cells and expresses the
polyoma virus mT oncogene (30). The pMv-src plasmid (a gift from Dr D.
Shalloway, Pennsylvania State University) codes for the chicken v-sm
gene product under the control of the Moloney murine leukemia virus
promoter (52).
In Vitro Kinase Assay. We used the procedure that was described
before(53)with minor modtflcations. Briefly, Tandgens were extracted on ￿e
with a solution of 137 mM NaCI, 20 m￿i Tris-HCI (pH 7.0), 0.9 m￿ CaCI2, 0.5
mM MgCI￿, 1% NP-40, 10% glycerol, 1 m￿ phenylmethylsuifonyl fluoride, 1
￿/mI leupeptin, 10 ￿/mI aprotinin, and 50 pg/mI sodium orthovanadate.
Clarified extracts were reacted with anti-polyorna tumor ascites fluki, and
immunocomplexes were collected using protein A-Sepharose (Pharmacta).
These were sequentialty washed with PBS, a soIut￿n of 100 m￿ Tris-HCI,
500 m￿ UCI (pH 7.0), and Idnase buffer [5 mp￿i MgCl2, 20 m￿ Tris-HCI (pH
7.5)]. [￿2p]ft￿W (20 ￿Ci in 5 mM Tris; pH 7.2; ICN) was added to the washed
immunoadsorbed complexes in 100 ￿d of kinase buffer. After incubation at
room temperature for 60 mm, the complexes were boiled in 5DB sample
buffer, and the proteins were resobied by SDS-PAGE Gels weretreated with
NaOH, dried, and exposed to Kodak XAR-5 film.
lmmunofluorescence Microscopy. Cells were grown on coverslips,
washed in PBS, and fixed in cold acetone(l00%)at -20#{176}C for 10 mm. Faxed
cells were rinsed three times in PBS before and after incubation with the
anlibodies as described (33). For CK detection, cells were reacted with a
mouse monodonal antibody agalnst rat CK8 (33) and a rabbit pc￿yclenal
antibody that recognazes rat CK14.5 Primary antibody reactions agalnst CKs
were detected with FITC-labeled antimouse and antirabbit antibodies. For
oncoprotein detection, cells were reacted with a rat monoclonal antibody (C4
supematant, agiftfrorn Dr. B. Griffin, Hammersmith Hospital, London), which
detects the polyoma virus wiki-type and mutant mT antigens (54), and a
commerciaHy available mouse monoclonal antibody agalnst Sm (Ref. 55;
Oncogene Science). These primary andbody reactions were revealed by
usrng biotin-conjugated antirat, andmouse, or antirabbit antibodies followed
by incubation with Fflt-lebeled streptavidin (Miersham). Observanons were
made with a Bio-Rad confocal scanning leser microscope, and images were
photographed directly from the video screen, using Kodak T-max 100 ASA
film, or printed direcfly with a Sony UP5100 printer.
Northern Analysis. Total RNA extraction was performed on exponen-
tially growing cell cultures, as described in the procedure of Chomczynski
and Sacchi (56). RNA samples (20 ￿g) were resolved by gel electrophore-
sis (1 .5% agarose gel containing formaldehyde) and transferred to a nylon
membrane (Amersham; Hybond-N; Refs. 30 and 44). Blots were hybrid-
ized with a 2.2-kb BamHI-EcoRl fragment of pMT3 corresponding to mT
oncogene and with the mouse CK14, CK8, human vimentin, and chicken
actin cDNA probes (30, 44), labeled according to the random priming
method of Feinberg and Vogelstemn (57). After hybridization, filters were
washed and exposed as described (30, 44).
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